Ecosystem
Beta Site
Search Results
58 items found for "Mesenchymal transition"
Posts (33)
- Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and...
promoted liver and kidney fibrosis and pathological angiogenesis, including occurrence of endothelial-to-mesenchymal transition.
- Cell-Type-Specific Effects of the Ovarian Cancer G-Protein Coupled Receptor (OGR1) on Inflammation..
However, in epithelial cells, OGR1 promotes epithelial to mesenchymal transition (EMT) and inflammation
- Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion ...
Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion of mesenchymal Application of mesenchymal stem cells (MSCs) as an emerging approach was recruited forthe treatment of
Other Pages (25)
- GPR56 signaling pathway network and its dynamics in the mesenchymal transition of glioblastoma
transition of glioblastoma Published date November 19, 2023 Abstract "G protein-coupled receptor 56 transition, making it a promising therapeutic target (Ganesh et al., 2022). transition in GBM. GPR56 signaling and mesenchymal transition." Authors Raksha A Ganesh , Krishnan Venkataraman , Ravi Sirdeshmukh Tags GPR56 /ADGRG1 , Mesenchymal transition
- Ascitic Shear Stress Activates GPCRs and Downregulates Mucin 15 to Promote OvarianCancer Malignancy
display heightened G protein-coupled receptor mechanosignaling and the induction of an epithelial to mesenchymal-like transition through p38α mitogen-activated protein kinase and mucin 15 modulation. Nordsletten Tags G-protein coupled receptors (GPCR) , NF-κB , PLCβ , ascitic currents , epithelial to mesenchymal transition (EMT) , fluid shear stress , glycocalyx , high grade serous ovarian cancer , mechanotransduction
- Activation of PI3K/Akt pathway by G protein-coupled receptor 37 promotes resistance to cisplatin-induced apoptosis in non-small cell lung cancer
formation and growth. (3) GPR37 activates PI3K/Akt/mTOR signal transduction pathways to mediate epithelial-mesenchymal transition (EMT), thereby promoting the progression of NSCLC.